Does reduced erythrocyte C3b receptor (CR1) activity contribute to the pathogenesis of yersinia triggered reactive arthritis?
AUTOR(ES)
Lahesmaa, R
RESUMO
Erythrocyte C3b receptor (CR1) activity was measured in 27 patients with yersinia triggered reactive arthritis and in 151 control subjects, including 36 patients with uncomplicated yersiniosis and 115 healthy subjects. CR1 was measured by the immune adherence haemagglutination method. Patients with yersinia triggered reactive arthritis had reduced levels of CR1 compared with the controls. This difference was mainly due to the finding that five out of six HLA B27 negative patients with arthritis had decreased CR1 activity. Such a quantitative difference may contribute to the pathogenesis of reactive arthritis by affecting the clearance of immune complexes.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1004628Documentos Relacionados
- Relationships between C3b receptor (CR1) activity of erythrocytes and positive Coombs' tests.
- In vivo binding of circulating immune complexes by C3b receptors (CR1) of transfused erythrocytes.
- Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism.
- IgA-anti-yersinia antibodies in yersinia triggered reactive arthritis.
- Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule.
